PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab

Background. The primary challenge of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) patient care is the early detection of relapses to prevent organ damage and increase survival. Potential biomarkers for relapses are ANCA and B cells, but their predictive value is a matter o...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dam, Laura S, Dirikgil, Ebru, Bredewold, Edwin W, Ray, Argho, Bakker, Jaap A, van Kooten, Cees, Rabelink, Ton J, Teng, Yoe K Onno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311572/
https://www.ncbi.nlm.nih.gov/pubmed/32601673
http://dx.doi.org/10.1093/ndt/gfaa066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311572/
https://www.ncbi.nlm.nih.gov/pubmed/32601673
http://dx.doi.org/10.1093/ndt/gfaa066

Ejemplares similares